Jeffrey S. Glenn
Net Worth

Last updated:

What is Jeffrey S. Glenn net worth?

The estimated net worth of Dr. Jeffrey S. Glenn is at least $832,062 as of 22 Dec 2022. He owns shares worth $314,562 as insider and has received compensation worth at least $517,500 in Eiger BioPharmaceuticals, Inc..

What is the salary of Jeffrey S. Glenn?

Dr. Jeffrey S. Glenn salary is $57,500 per year as Founder, Scientific Advisor & Independent Director in Eiger BioPharmaceuticals, Inc..

How old is Jeffrey S. Glenn?

Dr. Jeffrey S. Glenn is 62 years old, born in 1963.

What stocks does Jeffrey S. Glenn currently own?

As insider, Dr. Jeffrey S. Glenn owns shares in one company:

Company Title Shares Price per share Total value
Eiger BioPharmaceuticals, Inc. (EIGR) Founder, Scientific Advisor & Independent Director 182,355 $1.73 $314,562

What does Eiger BioPharmaceuticals, Inc. do?

Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infection. The company's product candidate also include Lambda, which targets type III interferon receptors that has completed Phase II clinical trials; Lonafarnib for the treatment of progeria and progeroid laminopathies; and Avexitide for the treatment of congenital hyperinsulinism, as well as has completed Phase II clinical trials to treat post-bariatric hypoglycemia. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is headquartered in Palo Alto, California.

EIGR logo
EIGR
Eiger BioPharmaceuticals, Inc.
$1.73

Jeffrey S. Glenn insider trading

Eiger BioPharmaceuticals, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 100,000 $1.28 $128,000
Purchase
Common Stock 5,000 N/A N/A
Purchase
Common Stock 5,000 N/A N/A
Purchase
Common Stock 30,000 $5.03 $150,810
Purchase
Common Stock 15,000 $9.53 $142,950
Purchase
Common Stock 460 $12.9 $5,934
Purchase
Common Stock 15,000 $12.73 $190,950

Eiger BioPharmaceuticals key executives

Eiger BioPharmaceuticals, Inc. executives and other stock owners filed with the SEC:

  • Dr. Evan Loh (66) Chief Executive Officer of Paratek Pharmaceuticals & Director
  • Dr. Jeffrey S. Glenn (62) Founder, Scientific Advisor & Independent Director
  • Mr. David A. Cory M.B.A., R.Ph., R.Ph, MBA (61) Bus. Founder, Pres, Chief Executive Officer & Director
  • Mr. Eldon C. Mayer III, M.B.A. (64) Executive Vice President & Chief Commercial Officer
  • Mr. Sriram Ryali M.B.A. (44) Chief Financial Officer